Financings in Brief: Lifecore Biomedical
This article was originally published in The Gray Sheet
Executive Summary
Lifecore Biomedical: Net proceeds from secondary offering reach approximately $23 mil. following the purchase of the entire over-allotment option of 330,000 shares by underwriters Piper Jaffray and Needham & Company. The Chaska, Minnesota-based firm has about 10.5 mil. shares outstanding after the offering, completed in October ("The Gray Sheet" Oct. 30, p. 17)...